News

Medivir and Janssen are expected to initiate an R&D program aimed at co-developing drugs based on the inhibition of the dengue NS3 protease activity. Both companies will be

Following the result, Renovo will conduct further exploratory analysis and determine the future of the Juvista development programme. The double blind, placebo controlled trial was designed to evaluate

Developed at Global Research and Development (GRAND) Center in Navi Mumbai, PacliALL offers shorter infusion time and elimination of need of premedication for the patients, Panacea Biotec said.

The Taiwan-based CTPS, which is an ISO/IEC 17025 certified, GLP compliant and AAALAC accredited facility specializing in general nonclinical toxicity and safety testing, genetic toxicology, reproductive toxicology, immunotoxicity

LibiGel is being developed to treat female sexual dysfunction (FSD), hypoactive sexual desire disorder (HSDD) in menopausal women to be specific, for which there is no FDA approved

The network is intended to generate positive synergies for the company and home-based billers and create a win-win situation for both. The home-based biller would represent Med DataCare

Currently, only those who are 17 and older can buy it without a doctor’s order, Reuters.com reported. Initially approved in 1999, Plan B contains a higher dose of

Children’s Hospital Division of Endocrinology physician and researcher Umut Ozcan has demonstrated that the regulatory protein XBP-1s, when activated artificially in the liver, can normalize high blood sugar

The collaboration came in line with EEC’s special attention to the pharmaceutical sector primarily because of the quality of jobs they will create and the products they will